Patent · US Active

Topical localized isoxazoline formulation

US9532978B2 · kind B2 · utility

11Cited by
2References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 28, 2015
Grant dateJan 3, 2017
Priority date
Expiry dateSep 28, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P33/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides topical localized formulations comprising an isoxazoline compound and a pharmaceutically or veterinary acceptable liquid carrier vehicle comprising N,N-diethyl-3-methylbenzamide as a solvent and an improved method for controlling, and preventing parasite infestation in animals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.